Health Care: Drugs

Immunoclin Corp (IMCL: OTC)

$4 n/a | n/a%
10/10/14 - 01:26 PM ET
Company Cash Flow
Jan 2014 Feb 2013 Feb 2012
Cash Flow From Operating Activities
Net Income (Loss) -12.98M -338.00 -84.70K
Operating Gains/Losses 0.00 -39.50K 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00
(Increase) Decrease In Receivables 12.34K 0.00 0.00
(Increase) Decrease in Inventories 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00
(Decrease) Increase In Payables -193.69K -6.86K 50.47K
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 469.89K 0.00 4.82K
Other Non-Cash Items 12.37M 39.00K 0.00
Net Cash From Continuing Operations -110.63K -7.70K -29.41K
Net Cash From Discontinued Operations 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -110.63K -7.70K -29.41K
Sale of Property, Plant & Equipment 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -6.59K 0.00 0.00
Acquisitions 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -6.59K 0.00 0.00
Issuance of Debt 2.03K 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 0.00 12.55K 12.72K
Repayment of Long-Term Debt 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00
Other Financing Charges, Net 0.00 -17.21K 20.07K
Net Cash From Financing Activities 2.03K -4.66K 32.79K
Effect of Exchange Rate Changes 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -115.19K -12.35K 3.39K

Portfolios with IMCL

Latest IMCL Headlines from TheStreet

More Financial News for IMCL

Press Releases for IMCL

See All Press Releases

Partner Headlines for IMCL

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter